Jingang Huang
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy.
Journal: Nature communications
Published: September 23, 2019
Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis.
Journal: Science translational medicine
Published: September 20, 2019
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target.
Journal: Oncotarget
Published: July 23, 2017
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: November 14, 2016
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: December 08, 2014
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis.
Journal: Nature medicine
Published: July 14, 2014
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: July 04, 2014
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
Journal: Annals of the rheumatic diseases
Published: April 14, 2014
Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: January 23, 2014
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
Journal: Annals of the rheumatic diseases
Published: January 22, 2014
Last Updated: 09/26/2026